clindamycin has been researched along with Lymphatic Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Judd, O; Malik, T; Medcalf, M | 1 |
| Berman, EL; Bersoff-Matcha, S; Cerva, D; Druckenbrod, G; Earls, J; Fatteh, N; Hanfling, D; Harper, S; Mayer, TA; Murphy, C; Napoli, A; Nayyar, A; Nguyen, M; Pauze, D; Rosenthal, J | 1 |
2 other study(ies) available for clindamycin and Lymphatic Diseases
| Article | Year |
|---|---|
Case 2: An unusual presentation of an unusual condition (Case Presentation).
Topics: Adolescent; Anti-Bacterial Agents; Anticoagulants; Clindamycin; Female; Fever; Heparin, Low-Molecular-Weight; Humans; Jugular Veins; Lymphatic Diseases; Ultrasonography; Venous Thromboembolism | 2008 |
Clinical presentation of inhalational anthrax following bioterrorism exposure: report of 2 surviving patients.
Topics: Anthrax; Anti-Bacterial Agents; Bacillus anthracis; Bioterrorism; Blood; Ciprofloxacin; Clindamycin; District of Columbia; Dyspnea; Fever; Humans; Lymphatic Diseases; Male; Mediastinal Diseases; Middle Aged; Occupational Exposure; Pleural Effusion; Polymerase Chain Reaction; Postal Service; Radiography, Thoracic; Respiratory Tract Infections; Rifampin; Spores, Bacterial; Survivors; Tomography, X-Ray Computed | 2001 |